BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 18386334)

  • 1. Novel human pathological mutations. Gene Symbol: CYP21A2. Disease: Non-classic 21-hydroxylase deficiency.
    Concolino P; Santonocito C; Minucci A; Carrozza C; Zuppi C; Capoluongo E; Giardina B
    Hum Genet; 2007 Dec; 122(5):559. PubMed ID: 18386334
    [No Abstract]   [Full Text] [Related]  

  • 2. Gene symbol: CYP21A2. Disease: Non-classic 21-Hydroxylase deficiency.
    Capoluongo E; Concolino P; Vendittelli F; Zuppi C
    Hum Genet; 2008 Jun; 123(5):553. PubMed ID: 20960659
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel human pathological mutations. Gene symbol: CYP21A2. Disease: adrenal hyperplasia.
    Carvalho B; Marques CJ; Carvalho D; Barros A; Carvalho F
    Hum Genet; 2010 Apr; 127(4):482-3. PubMed ID: 21488305
    [No Abstract]   [Full Text] [Related]  

  • 4. [From gene to disease: adrenogenital syndrome and the CYP21A2 gene].
    Claahsen-van der Grinten HL; Hoefsloot LH
    Ned Tijdschr Geneeskd; 2007 May; 151(21):1174-7. PubMed ID: 17557757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene symbol: CYP21A2. Disease: steroid 21-hydroxylase deficiency.
    Tardy V
    Hum Genet; 2006 Apr; 119(3):363. PubMed ID: 17230656
    [No Abstract]   [Full Text] [Related]  

  • 6. Gene symbol: CYP21A2. Disease: adrenal hyperplasia, CYP21.
    Dain L; Minutolo C; Buzzalino N; Belli S; Oneto A; Charreau E; Alba L
    Hum Genet; 2006 Apr; 119(3):363. PubMed ID: 17230657
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene symbol: CYP21A2. Disease: Adrenal hyperplasia.
    Capoluongo E; Concolino P; Carrozza C; Santonocito C; Zuppi C
    Hum Genet; 2008 Jun; 123(5):550. PubMed ID: 20960642
    [No Abstract]   [Full Text] [Related]  

  • 8. Gene symbol: CYP21A2. Disease: Adrenal hyperplasia.
    Capoluongo E; Concolino P; Vendittelli F; Zuppi C
    Hum Genet; 2008 Jun; 123(5):549-50. PubMed ID: 20960641
    [No Abstract]   [Full Text] [Related]  

  • 9. Gene symbol: CYP21A2. Disease: Adrenal hyperplasia.
    Capoluongo E; Concolino P; Minucci A; Giardina B
    Hum Genet; 2008 Jun; 123(5):550. PubMed ID: 20960643
    [No Abstract]   [Full Text] [Related]  

  • 10. Three novel CYP21A2 mutations and their protein modelling in patients with classical 21-hydroxylase deficiency from northeastern Iran.
    Baradaran-Heravi A; Vakili R; Robins T; Carlsson J; Ghaemi N; A'rabi A; Abbaszadegan MR
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):335-41. PubMed ID: 17573904
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid withdrawal - heterozygous carriers of congenital adrenal hyperplasia at risk?
    Brackmann F; Dörr HG; Bartram CR; Hinderhofer K; Holter W; Langer T
    Klin Padiatr; 2012 Oct; 224(6):392-3. PubMed ID: 22915453
    [No Abstract]   [Full Text] [Related]  

  • 12. [Virilizing congenital adrenogenital syndrome with a de novo I172N mutation: study of a new case].
    Díez López I; Rodríguez Estévez A; González Molina E; Martínez Ayucar M; Rodríguez Pérez B; Ezquieta Zubicaray B
    An Pediatr (Barc); 2010 Jan; 72(1):72-8. PubMed ID: 19819201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of the human steroid 21-hydroxylase gene and its mutant variant C169R in insect cells and functional analysis of expression products].
    Grishchuk IuV; Rubtsov PM; Belzhelarskaia SN
    Mol Biol (Mosk); 2007; 41(1):71-8. PubMed ID: 17380893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel mutations in Japanese patients with 21-hydroxylase deficiency.
    Usui T; Nishisho K; Kaji M; Ikuno N; Yorifuji T; Yasuda T; Kuzuya H; Shimatsu A
    Horm Res; 2004; 61(3):126-32. PubMed ID: 14676460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bilateral adrenal myelolipoma associated with adrenogenital syndrome.
    Sakaki M; Izaki H; Fukumori T; Taue R; Kishimoto T; Kanayama HO
    Int J Urol; 2006 Jun; 13(6):801-2. PubMed ID: 16834664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Congenital adrenal hyperplasia].
    Bouvattier C; Chatelain P
    Rev Prat; 2008 May; 58(9):990-4. PubMed ID: 18672665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional studies of CYP21A2 mutants complement structural and clinical predictions of disease severity in CAH.
    Barbaro M; Soardi FC; de Mello MP; Wedell A; Lajic S
    Clin Endocrinol (Oxf); 2012 May; 76(5):766-8. PubMed ID: 22040027
    [No Abstract]   [Full Text] [Related]  

  • 18. Identification of a novel compound heterozygous mutation of the CYP21A2 gene causing 21‑hydroxylase deficiency in a Chinese pedigree.
    Liu J; Zhang X; Zhang H; Fang L; Xu J; Guan Q; Xu C
    Mol Med Rep; 2018 Mar; 17(3):4265-4272. PubMed ID: 29328376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonsense mutation causing steroid 21-hydroxylase deficiency.
    Globerman H; Amor M; Parker KL; New MI; White PC
    J Clin Invest; 1988 Jul; 82(1):139-44. PubMed ID: 3267225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [21 hydroxylase deficiency: new strategies emerging from molecular studies].
    Morel Y; Tardy V; Costa JM; Forest MG; David M
    Ann Endocrinol (Paris); 2003 Dec; 64(6):456-70. PubMed ID: 15067252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.